site stats

Jerry mcmahon harpoon

Webb26 okt. 2024 · Harpoon Therapeutics (NASDAQ: HARP) has appointed Julie Eastland as the company’s new President and CEO effective Nov. 08. Ms. Eastland, a current board member of the company, will replace Jerry ... WebbGet Jerry McMahon's email address (j*****@stormtherapeutics.com) and phone number (203222....) at RocketReach. Get 5 free searches. ... President and CEO @ Harpoon Therapeutics; Adjunct Professor of Medical Oncology and Yale Comprehensive Cancer Center @ Yale School of Medicine;

Harpoon Therapeutics, Inc. Announces Executive Changes

Webb7 sep. 2024 · Dr. Jerry McMahon added: ... Dr. McMahon was President and CEO of NASDAQ listed Harpoon Therapeutics, building the Company from early stage through to IPO, follow-on financings, ... Webb2 juli 2024 · Following these changes, Harpoon’s board will be composed of nine directors. “Jo is an accomplished executive with an impressive track record of scientific achievement and drug development,” said Jerry McMahon, Ph.D., President and Chief Executive Officer of Harpoon Therapeutics. felnőtt oktatási központ és gimnázium https://all-walls.com

Harpoon Therapeutics Announces Completion of $45M Series B …

Webb13 dec. 2016 · “We’re honored that Jerry is joining Harpoon as President and CEO. He is a visionary and hands-on leader with a broad range of strategic expertise in private and public biotechnology... Webb10 apr. 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced that Julie Eastland, President and Chief Executive Officer, and Luke Walker, M.D., Chief Medical Officer, will participate in a panel … Webb13 mars 2024 · Net loss for the fourth quarter ended December 31st, 2024 was $14.3 million, compared to $9.7 million for the fourth quarter ended December 31st, 2024. Net loss for the year ended December 31st ... hotels in nyanya abuja

Harpoon Therapeutics - HARP Stock Forecast, Price & News

Category:Harpoon Therapeutics Announces Change to Management Team …

Tags:Jerry mcmahon harpoon

Jerry mcmahon harpoon

About Leadership Team TriTAC™ Harpoon Therapeutics

WebbFrom 2016 to late 2024 Jerry was President and CEO of NASDAQ listed Harpoon Therapeutics building the Company from early stage through to IPO, follow-on financings, ... Jerry McMahon. CEO & President. View in org chart. Discover similar people. Jeffrey Cote. CEO & President at Sensata. Mary Monnat. CEO & President at LifeWorks NW. Webb7 sep. 2024 · Dr. Jerry McMahon added: “STORM is well positioned to fulfil its ambition of becoming the global leader in the field of RME. STORM’s first-in-class clinical candidate STC-15, an orally-bioavailable, highly selective METTL3 inhibitor, is on schedule to start initial clinical studies in solid tumors in 2024 and will be the first first-ever RME inhibitor …

Jerry mcmahon harpoon

Did you know?

Webb25 maj 2024 · “We are delighted to have top-tier investors supporting the Series B financing, and welcome new investors as Harpoon shareholders,” said Jerry McMahon, PhD, President and Chief Executive ...

WebbGerald McMahon, Ph.D., President and CEO of Harpoon About the Phase 1/2a Trial for HPN536 HPN536 is a 50-kD single polypeptide that contains three binding domains - to human mesothelin, human serum albumin and human CD3.The Phase 1/2a trial is a multicenter, open-label study designed to evaluate the safety, tolerability, … Webb7 sep. 2024 · McMahon has held scientific, pharmaceutical and venture capital positions and has been the CEO or President of multiple biotechnology companies leading novel therapeutic programs from discovery...

Webb27 okt. 2024 · Jerry McMahon is resigning from his president and chief executive posts, Harpoon announced after the closing bell Tuesday, as the company hopes to move past a months-long slide that’s seen $HARP ... Webb7 sep. 2024 · Dr. McMahon has held scientific, pharmaceutical and venture capital positions and has been the CEO or President of multiple biotechnology companies leading novel therapeutic programs from discovery and development to drug approvals for internal and in-licensed products.

WebbJerry McMahon became CEO of the Company in 2016. McMahon has entered into a retirement and transition agreement with Harpoon and will serve as an advisor. Gerald McMahon, Ph.D. has served as the Company’s President, Chief Executive Officer and a member of the Company’s Board since December 2016.

Webb2 aug. 2024 · In response, on July 30, 2024, Harpoon filed a supplemental submission, accompanied by two affidavits, from Lilia R. Lopez, a California attorney admitted to Delaware pro hac vice, who represents Harpoon in this action, and from Dr. Gerald McMahon, Harpoon’s President and CEO.2 The supplemental submission was also … hotels in nyahururu kenyaWebbHarpoon is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that unleash the natural power of the T cells to fight cancer and other diseases. At the heart of Harpoon’s approach is a novel antibody-derived platform called TriTAC ® (Tri-specific T cell Activating Construct) designed for targeted penetration ... felnott pelenkaWebb11 mars 2024 · Harpoon Therapeutics, Inc. (NASDAQ:HARP) Q4 2024 Earnings Conference Call March 10, 2024 4:30 PM ETCompany Participants. Gerald McMahon - President and CEO. Georgia Erbez - CFO. Natalie Sacks ... felnőtt orvosi ügyelet zugló